BCAX — Bicara Therapeutics Inc.

Ownership history in TPG GP A, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which TPG GP A, LLC reported a position in Bicara Therapeutics Inc. (BCAX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.59% (2025 Q3)
Avg. % of fund
1.48%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 3,010,425 — 0% 1.89% $50.7M $16.83
2025 Q3 UNCHANGED 3,010,425 — 0% 2.59% $47.5M $15.79
2025 Q2 UNCHANGED 3,010,425 — 0% 1.49% $28.0M $9.29
2025 Q1 UNCHANGED 3,010,425 — 0% 0.77% $39.2M $13.03
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BCAX price (monthly, adj. close)

Other funds also holding BCAX

As of 2025 Q4 — sorted by position size

Omega Fund Management, LLC 3Y 7Y 12.95% ACORN CAPITAL ADVISORS, LLC 3.67% Siren, L.L.C. 2.62% Vestal Point Capital, LP 2.05% Aisling Capital Management LP 3Y 7Y 2.0% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.2% DAFNA Capital Management LLC 3Y 7Y 1.02% Deep Track Capital, LP 3Y 0.78% Palo Alto Investors LP 3Y 7Y 0.7% Atle Fund Management AB 3Y 7Y 0.6%
← Back to TPG GP A, LLC Holdings